Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hajali, 2008, The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography, Br J Ophthalmol, 92, 1065, 10.1136/bjo.2008.138560
Testa, 2014, Macular abnormalities in Italian patients with retinitis pigmentosa, Br J Ophthalmol, 98, 946, 10.1136/bjophthalmol-2013-304082
Adackapara, 2008, Prevalence of cystoid macular edema and stability in OCT retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial, Retina (Philadelphia, Pa), 28, 103, 10.1097/IAE.0b013e31809862aa
Ozdemir, 2005, Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa, Acta Ophthalmol Scand, 83, 248, 10.1111/j.1600-0420.2005.00395.x
Liew, 2014, A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010, BMJ Open, 4, e004015, 10.1136/bmjopen-2013-004015
Scorolli, 2007, Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone, Arch Ophthalmol, 125, 759, 10.1001/archopht.125.6.759
Kent, 2000, Macular oedema: the role of soluble mediators, Br J Ophthalmol, 84, 542, 10.1136/bjo.84.5.542
Vinores, 1999, Cellular mechanisms of blood-retinal barrier dysfunction in macular edema, Doc Ophthalmol, 97, 217, 10.1023/A:1002136712070
Rizzolo, 1997, Polarity and the development of the outer blood-retinal barrier, Histol Histopathol, 12, 1057
Vinores, 2010, The retina and its disorders. Breakdown of the blood-Retinal Barrier, 52
Vinores, 1995, Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization, Histol Histopathol, 10, 913
Spalton, 1978, Immunological studies in retinitis pigmentosa associated with retinal vascular leakage, Br J Ophthalmol, 62, 183, 10.1136/bjo.62.3.183
Miyake, 2002, Prostaglandins and cystoid macular edema, Surv Ophthalmol, 47, S203, 10.1016/S0039-6257(02)00294-1
Enea, 1989, Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes, Arch Ophthalmol, 107, 270, 10.1001/archopht.1989.01070010276036
Kuijpers, 1998, Treatment of cystoid macular edema with octreotide, N Engl J Med, 338, 624, 10.1056/NEJM199802263380917
Claudio, 1994, Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha, Lab Invest, 70, 850
Hamann, 2002, Molecular mechanisms of water transport in the eye, Int Rev Cytol, 395, 10.1016/S0074-7696(02)15016-9
Reichenbach, 2007, Muller cells as players in retinal degeneration and edema, Graefes Arch Clin Exp Ophthalmol, 245, 627, 10.1007/s00417-006-0516-y
Hibino, 2010, Inwardly rectifying potassium channels: their structure, function, and physiological roles, Physiol Rev, 90, 291, 10.1152/physrev.00021.2009
Makiyama, 2014, Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography, Retina, 34, 981, 10.1097/IAE.0000000000000010
Rahi, 1973, Autoimmunity and the retina. II. Raised serum IgM levels in retinitis pigmentosa, Br J Ophthalmol, 57, 904, 10.1136/bjo.57.12.904
Spiro, 1978, Serum IgM in retinitis pigmentosa: a genetic study, Clin Genet, 13, 295, 10.1111/j.1399-0004.1978.tb01184.x
Heckenlively, 1996, Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations, Trans Am Ophthalmol Soc, 94, 179
Chant, 1985, Autoimmunity in hereditary retinal degeneration. I. Basic studies, Br J Ophthalmol, 69, 19, 10.1136/bjo.69.1.19
Garcia-Arumi, 2003, Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa, Ophthalmology, 110, 1164, 10.1016/S0161-6420(03)00259-8
Schepens, 1984, Role of the vitreous in cystoid macular edema, Surv Ophthalmol, 28, 499, 10.1016/0039-6257(84)90232-7
Takezawa, 2011, Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa, Clin Ophthalmol, 5, 245
Hee, 1995, Quantitative assessment of macular edema with optical coherence tomography, Arch Ophthalmol, 113, 1019, 10.1001/archopht.1995.01100080071031
Hirakawa, 1999, Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa, Am J Ophthalmol, 128, 185, 10.1016/S0002-9394(99)00100-2
Apushkin, 2004, Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa, Ophthalmology, 111, 1899, 10.1016/j.ophtha.2004.04.019
Kim, 2013, Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa, Invest Ophthalmol Vis Sci, 54, 1303, 10.1167/iovs.12-10149
Oishi, 2009, Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa, Eye (Lond), 23, 1411, 10.1038/eye.2008.266
Aizawa, 2009, Correlation between visual function and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa, Eye (Lond), 23, 304, 10.1038/sj.eye.6703076
Sandberg, 2005, The association between visual acuity and central retinal thickness in retinitis pigmentosa, Invest Ophthalmol Vis Sci, 46, 3349, 10.1167/iovs.04-1383
Dinc, 2010, Correlation of retinal sensitivity and retinal thickness in central serous chorioretinopathy, Ophthalmologica, 224, 2, 10.1159/000233229
Okada, 2006, Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema, Eye (Lond), 20, 805, 10.1038/sj.eye.6702014
Carpineto, 2007, Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema, Retina (Philadelphia, Pa), 27, 21, 10.1097/01.iae.0000256658.71864.ca
Liew, 2015, Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa, Invest Ophthalmol Vis Sci, 56, 1531, 10.1167/iovs.14-15995
Kim, 2012, Association of p.P347L in the rhodopsin gene with early-onset cystoid macular edema in patients with retinitis pigmentosa, Ophthalmic Genet, 33, 96, 10.3109/13816810.2011.642453
Apushkin, 2007, Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa, Retina (Philadelphia, Pa), 27, 1112, 10.1097/IAE.0b013e31805f6b79
Chen, 1990, Long-term effect of acetazolamide in a patient with retinitis pigmentosa, Invest Ophthalmol Vis Sci, 31, 1914
Fishman, 2007, Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa, Br J Ophthalmol, 91, 743, 10.1136/bjo.2006.107466
Fishman, 1994, Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa, Ophthalmology, 101, 687, 10.1016/S0161-6420(94)31277-2
Fishman, 1989, Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa, Arch Ophthalmol, 107, 1445, 10.1001/archopht.1989.01070020519031
Fishman, 1993, Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa, Arch Ophthalmol, 111, 1640, 10.1001/archopht.1993.01090120062023
Genead, 2010, Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome, Arch Ophthalmol, 128, 1146, 10.1001/archophthalmol.2010.172
Grover, 2006, Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa, Am J Ophthalmol, 141, 850, 10.1016/j.ajo.2005.12.030
Grover, 1997, Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa, Retina (Philadelphia, Pa), 17, 222, 10.1097/00006982-199705000-00009
Ikeda, 2012, The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa, Graefes Arch Clin Exp Ophthalmol, 250, 809, 10.1007/s00417-011-1904-5
Ikeda, 2013, Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa, Br J Ophthalmolγ, 97, 1187, 10.1136/bjophthalmol-2012-303005
Orzalesi, 1993, Long-term treatment of retinitis pigmentosa with acetazolamide. A pilot study, Graefes Arch Clin Exp Ophthalmol, 231, 254, 10.1007/BF00919100
Pacella, 2014, Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports, Ophthalmol Eye Dis., 6, 21, 10.4137/OED.S13617
Thobani, 2011, The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis, Retina (Philadelphia, Pa), 31, 312, 10.1097/IAE.0b013e3181e587f9
Goren, 1961, The localization of diamox-S35 in the rabbit eye, Am J Ophthalmol., 51, 87, 10.1016/0002-9394(61)91315-0
Lin APO-N, S, 2015, Diseases of the head and neck, Conn's current therapy 2015, 323
Penfold, 2000, Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration, Clin Exp Immunol, 121, 458, 10.1046/j.1365-2249.2000.01316.x
Moshfeghi, 2003, Acute endophthalmitis following intravitreal triamcinolone acetonide injection, Am J Ophthalmol, 136, 791, 10.1016/S0002-9394(03)00483-5
Roth, 2003, Noninfectious endophthalmitis associated with intravitreal triamcinolone injection, Arch Ophthalmol, 121, 1279, 10.1001/archopht.121.9.1279
Jonas, 2001, Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy, Am J Ophthalmol, 131, 468, 10.1016/S0002-9394(00)00882-5
Ahn, 2014, The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review, Ophthalmic Surg Lasers Imaging Retina, 45, 160, 10.3928/23258160-20140131-03
Alhassan, 2013, Unilateral intravitreal dexamethasone implant for bilateral retinitis pigmentosa-related macular edema, Graefes Arch Clin Exp Ophthalmol, 251, 2827, 10.1007/s00417-013-2447-8
Barge, 2013, Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema, Case Rep Ophthalmol Med, 2013, 591681
Buchaim, 2013, [Intravitreal implantation of Ozurdex(R) chronic delivery system for management of macular edema related to retinitis pigmentosa: case report], Arq Bras Oftalmol, 76, 377, 10.1590/S0004-27492013000600013
Giusti, 2002, Deflazacort treatment of cystoid macular edema in patients affected by retinitis pigmentosa: a pilot study, Eur Rev Med Pharmacol Sci, 6, 1
Kim, 2006, Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa, Retina (Philadelphia, Pa), 26, 1094, 10.1097/01.iae.0000254897.86389.a5
Minnella, 2006, Optical coherence tomography and focal electroretinogram evaluation of cystoid macular edema secondary to retinitis pigmentosa treated with intravitreal triamcinolone: case report, Eur J Ophthalmol, 16, 883, 10.1177/112067210601600620
Patil, 2014, Coat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implant, Eye (Lond), 28, 449, 10.1038/eye.2013.314
Saatci, 2013, Bilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edema, Case Rep Ophthalmol, 4, 53, 10.1159/000350544
Sallum, 2003, Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case report, Adv Exp Med Biol, 533, 79, 10.1007/978-1-4615-0067-4_10
Saraiva, 2003, Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide, Ophthalmic Surg Lasers Imaging, 34, 398, 10.3928/1542-8877-20030901-11
Schaal, 2016, Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide, Can J Ophthalmol, 51, e113, 10.1016/j.jcjo.2015.12.021
Srour, 2013, Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa, Graefes Arch Clin Exp Ophthalmol, 251, 1501, 10.1007/s00417-012-2249-4
Urban, 2009, Subretinal triamcinolone acetonide associated with improvement of cystoid macular edema in a patient with retinitis pigmentosa, Retin Cases Brief Rep, 3, 47, 10.1097/ICB.0b013e318150d705
Wang, 2006, Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases, Adv Exp Med Biol, 572, 309, 10.1007/0-387-32442-9_43
Haller, 2010, Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion, Ophthalmology, 117, 1134, 10.1016/j.ophtha.2010.03.032
Scott, 2009, A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6, Arch Ophthalmol, 127, 1115, 10.1001/archophthalmol.2009.233
Park, 2013, Topical steroidal and nonsteroidal antiinflammatory drugs for the treatment of cystoid macular edema in retinitis pigmentosa, Retin Cases Brief Rep, 7, 134, 10.1097/ICB.0b013e31825a300f
Lemos Reis, 2015, Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome, Ophthalmologica, 233, 43, 10.1159/000368052
Brown, 2011, Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration, Ophthalmology, 118, 1089, 10.1016/j.ophtha.2011.02.039
Salom, 2008, Aqueous humor levels of vascular endothelial growth factor in retinitis pigmentosa, Invest Ophthalmol Vis Sci, 49, 3499, 10.1167/iovs.07-1168
Querques, 2009, Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa, Int Ophthalmol, 29, 103, 10.1007/s10792-007-9175-1
Yuzbasioglu, 2009, Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa, Curr Eye Res, 34, 231, 10.1080/02713680802710692
Artunay, 2009, Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa, J Ocul Pharmacol Ther, 25, 545, 10.1089/jop.2009.0089
Moustafa, 2015, Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa—a first case report and short review of the literature, BMC Ophthalmol, 15, 44, 10.1186/s12886-015-0033-z
Strong, 2016, Treatment of retinitis pigmentosa-associated cystoid macular oedema using intravitreal aflibercept (Eylea) despite minimal response to ranibizumab (Lucentis): a case report, Case Rep Ophthalmol, 7, 389, 10.1159/000448427
Shah, 2010, Treatment of retinitis pigmentosa-related cystoid macular edema with intravitreous ranibizumab, Retin Cases Brief Rep, 4, 291, 10.1097/ICB.0b013e3181af7b6c
Triolo, 2013, Spectral domain optical coherence tomography findings in patients with retinitis pigmentosa, Ophthalmic Res, 50, 160, 10.1159/000351681
Battaglia Parodi, 2012, Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab, J Ocul Pharmacol Ther, 28, 202, 10.1089/jop.2011.0140
Malik, 2010, Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab, Int Ophthalmol, 30, 425, 10.1007/s10792-009-9337-4
Melo, 2007, Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa, Acta Ophthalmol Scand, 85, 461, 10.1111/j.1600-0420.2006.00872.x
Aleman, 2001, Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome, Invest Ophthalmol Vis Sci, 42, 1873
Sandberg, 2014, The relationship of central foveal thickness to urinary iodine concentration in retinitis pigmentosa with or without cystoid macular edema, JAMA Ophthalmol, 132, 1209, 10.1001/jamaophthalmol.2014.1726
Newsome, 1987, Grid photocoagulation for macular edema in patients with retinitis pigmentosa, Am J Ophthalmol, 103, 161, 10.1016/S0002-9394(14)74221-7